Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging

Debabrata Ghosh, Fangyuan Xiong, Robert Mattrey, Shashank Sirsi, Kenneth Hoyt

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

The standard-of-care for evaluating breast tumor response to chemotherapeutic drug treatment remains the assessment of a tumor size change weeks after therapy begins. However, the tumor microenvironment is known to change drastically before any detectable change in physical size manifests. New clinical tools that can help determine early tumor response are urgently needed so we can both maximize the benefit of an effective therapeutic strategy and minimize the use of drugs that do not improve patient prognosis. To that end, the goal of this research project was to evaluate the utility of super-resolution ultrasound (SR-US) imaging for detecting the early tumor response (or lack thereof) to antiangiogenic-targeted therapy.

Original languageEnglish (US)
Title of host publication2017 IEEE International Ultrasonics Symposium, IUS 2017
PublisherIEEE Computer Society
ISBN (Electronic)9781538633830
DOIs
StatePublished - Oct 31 2017
Event2017 IEEE International Ultrasonics Symposium, IUS 2017 - Washington, United States
Duration: Sep 6 2017Sep 9 2017

Other

Other2017 IEEE International Ultrasonics Symposium, IUS 2017
CountryUnited States
CityWashington
Period9/6/179/9/17

Fingerprint

therapy
tumors
drugs
prognosis
research projects
breast

ASJC Scopus subject areas

  • Acoustics and Ultrasonics

Cite this

Ghosh, D., Xiong, F., Mattrey, R., Sirsi, S., & Hoyt, K. (2017). Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging. In 2017 IEEE International Ultrasonics Symposium, IUS 2017 [8092246] IEEE Computer Society. https://doi.org/10.1109/ULTSYM.2017.8092246

Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging. / Ghosh, Debabrata; Xiong, Fangyuan; Mattrey, Robert; Sirsi, Shashank; Hoyt, Kenneth.

2017 IEEE International Ultrasonics Symposium, IUS 2017. IEEE Computer Society, 2017. 8092246.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ghosh, D, Xiong, F, Mattrey, R, Sirsi, S & Hoyt, K 2017, Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging. in 2017 IEEE International Ultrasonics Symposium, IUS 2017., 8092246, IEEE Computer Society, 2017 IEEE International Ultrasonics Symposium, IUS 2017, Washington, United States, 9/6/17. https://doi.org/10.1109/ULTSYM.2017.8092246
Ghosh D, Xiong F, Mattrey R, Sirsi S, Hoyt K. Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging. In 2017 IEEE International Ultrasonics Symposium, IUS 2017. IEEE Computer Society. 2017. 8092246 https://doi.org/10.1109/ULTSYM.2017.8092246
Ghosh, Debabrata ; Xiong, Fangyuan ; Mattrey, Robert ; Sirsi, Shashank ; Hoyt, Kenneth. / Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging. 2017 IEEE International Ultrasonics Symposium, IUS 2017. IEEE Computer Society, 2017.
@inproceedings{587999f8b0be438ab5622cfc65fe258d,
title = "Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging",
abstract = "The standard-of-care for evaluating breast tumor response to chemotherapeutic drug treatment remains the assessment of a tumor size change weeks after therapy begins. However, the tumor microenvironment is known to change drastically before any detectable change in physical size manifests. New clinical tools that can help determine early tumor response are urgently needed so we can both maximize the benefit of an effective therapeutic strategy and minimize the use of drugs that do not improve patient prognosis. To that end, the goal of this research project was to evaluate the utility of super-resolution ultrasound (SR-US) imaging for detecting the early tumor response (or lack thereof) to antiangiogenic-targeted therapy.",
author = "Debabrata Ghosh and Fangyuan Xiong and Robert Mattrey and Shashank Sirsi and Kenneth Hoyt",
year = "2017",
month = "10",
day = "31",
doi = "10.1109/ULTSYM.2017.8092246",
language = "English (US)",
booktitle = "2017 IEEE International Ultrasonics Symposium, IUS 2017",
publisher = "IEEE Computer Society",

}

TY - GEN

T1 - Monitoring early tumor response to vascular targeted therapy using super-resolution ultrasound imaging

AU - Ghosh, Debabrata

AU - Xiong, Fangyuan

AU - Mattrey, Robert

AU - Sirsi, Shashank

AU - Hoyt, Kenneth

PY - 2017/10/31

Y1 - 2017/10/31

N2 - The standard-of-care for evaluating breast tumor response to chemotherapeutic drug treatment remains the assessment of a tumor size change weeks after therapy begins. However, the tumor microenvironment is known to change drastically before any detectable change in physical size manifests. New clinical tools that can help determine early tumor response are urgently needed so we can both maximize the benefit of an effective therapeutic strategy and minimize the use of drugs that do not improve patient prognosis. To that end, the goal of this research project was to evaluate the utility of super-resolution ultrasound (SR-US) imaging for detecting the early tumor response (or lack thereof) to antiangiogenic-targeted therapy.

AB - The standard-of-care for evaluating breast tumor response to chemotherapeutic drug treatment remains the assessment of a tumor size change weeks after therapy begins. However, the tumor microenvironment is known to change drastically before any detectable change in physical size manifests. New clinical tools that can help determine early tumor response are urgently needed so we can both maximize the benefit of an effective therapeutic strategy and minimize the use of drugs that do not improve patient prognosis. To that end, the goal of this research project was to evaluate the utility of super-resolution ultrasound (SR-US) imaging for detecting the early tumor response (or lack thereof) to antiangiogenic-targeted therapy.

UR - http://www.scopus.com/inward/record.url?scp=85039441128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039441128&partnerID=8YFLogxK

U2 - 10.1109/ULTSYM.2017.8092246

DO - 10.1109/ULTSYM.2017.8092246

M3 - Conference contribution

AN - SCOPUS:85039441128

BT - 2017 IEEE International Ultrasonics Symposium, IUS 2017

PB - IEEE Computer Society

ER -